| Primary |
| Depression |
45.0% |
| Drug Use For Unknown Indication |
17.4% |
| Anxiety |
12.6% |
| Product Used For Unknown Indication |
4.7% |
| Panic Attack |
3.1% |
| Obsessive-compulsive Disorder |
2.3% |
| Stress |
2.2% |
| Hypertension |
2.0% |
| Pain |
1.6% |
| Panic Disorder |
1.1% |
| Prophylaxis |
1.1% |
| Asthma |
1.0% |
| Bipolar Disorder |
1.0% |
| Anxiety Disorder |
0.9% |
| Arthritis |
0.7% |
| Depressed Mood |
0.7% |
| Postpartum Depression |
0.7% |
| Back Pain |
0.6% |
| Hypothyroidism |
0.6% |
| Major Depression |
0.6% |
|
| Drug Withdrawal Syndrome |
19.4% |
| Suicide Attempt |
13.8% |
| Withdrawal Syndrome |
13.2% |
| Suicidal Ideation |
12.8% |
| Vomiting |
6.2% |
| Weight Increased |
6.2% |
| Tremor |
5.9% |
| Vertigo |
4.1% |
| Completed Suicide |
2.9% |
| Overdose |
2.4% |
| Thinking Abnormal |
1.8% |
| Weight Decreased |
1.6% |
| Vision Blurred |
1.5% |
| Ill-defined Disorder |
1.4% |
| Suicidal Behaviour |
1.4% |
| Visual Disturbance |
1.3% |
| Tearfulness |
1.1% |
| Paraesthesia |
1.0% |
| Sleep Disorder |
1.0% |
| Visual Impairment |
1.0% |
|
| Secondary |
| Depression |
30.5% |
| Product Used For Unknown Indication |
27.1% |
| Drug Use For Unknown Indication |
10.4% |
| Anxiety |
8.9% |
| Sedation |
3.5% |
| Myocardial Ischaemia |
2.5% |
| Analgesic Therapy |
2.0% |
| Depressed Mood |
1.7% |
| Muscle Spasms |
1.6% |
| Panic Disorder |
1.3% |
| Dyspepsia |
1.2% |
| Prophylaxis |
1.2% |
| Extrapyramidal Disorder |
1.1% |
| Neck Pain |
1.1% |
| Oculogyric Crisis |
1.1% |
| Post-traumatic Stress Disorder |
1.1% |
| Psychotic Disorder |
1.1% |
| Insomnia |
0.9% |
| Phobia |
0.9% |
| Cardiac Disorder |
0.8% |
|
| Suicide Attempt |
22.9% |
| Muscle Contractions Involuntary |
14.0% |
| Withdrawal Syndrome |
11.5% |
| Vomiting |
10.2% |
| Weight Increased |
8.9% |
| Suicidal Ideation |
4.5% |
| Serotonin Syndrome |
3.2% |
| Tremor |
3.2% |
| Completed Suicide |
2.5% |
| Thrombocytopenia |
2.5% |
| Urinary Retention |
2.5% |
| Multiple Drug Overdose Intentional |
1.9% |
| Sinus Tachycardia |
1.9% |
| Vision Blurred |
1.9% |
| Weight Decreased |
1.9% |
| Dry Mouth |
1.3% |
| Hepatocellular Injury |
1.3% |
| Intentional Overdose |
1.3% |
| Overdose |
1.3% |
| Oxygen Saturation Decreased |
1.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.3% |
| Drug Use For Unknown Indication |
18.3% |
| Depression |
10.2% |
| Hypertension |
7.5% |
| Rheumatoid Arthritis |
6.6% |
| Osteoporosis |
3.8% |
| Asthma |
3.3% |
| Hypercholesterolaemia |
3.3% |
| Coronary Artery Disease |
2.6% |
| Prophylaxis |
2.6% |
| Arthritis |
2.2% |
| Diabetes Mellitus |
2.2% |
| Non-small Cell Lung Cancer |
2.2% |
| Pain |
2.2% |
| Parkinson's Disease |
2.2% |
| Anxiety |
1.8% |
| Schizophrenia |
1.8% |
| Type 2 Diabetes Mellitus |
1.8% |
| Anticoagulant Therapy |
1.5% |
| Crohn's Disease |
1.5% |
|
| Somnolence |
10.0% |
| Suicidal Ideation |
10.0% |
| Renal Failure Acute |
8.3% |
| Tremor |
6.7% |
| Blood Glucose Increased |
5.0% |
| Diabetes Mellitus |
5.0% |
| Hypocalcaemia |
5.0% |
| Pulmonary Hypertension |
5.0% |
| Suicide Attempt |
5.0% |
| Thrombocytopenia |
5.0% |
| Weight Increased |
5.0% |
| Anaphylactic Shock |
3.3% |
| Cholangitis |
3.3% |
| Dyspnoea |
3.3% |
| Endophthalmitis |
3.3% |
| Mania |
3.3% |
| Metastases To Central Nervous System |
3.3% |
| Nausea |
3.3% |
| Nervous System Disorder |
3.3% |
| Pain In Extremity |
3.3% |
|
| Interacting |
| Product Used For Unknown Indication |
16.5% |
| Analgesic Therapy |
15.7% |
| Depression |
10.2% |
| Muscle Spasms |
9.4% |
| Sedation |
9.4% |
| Neck Pain |
7.9% |
| Schizophrenia |
6.3% |
| Dyspepsia |
4.7% |
| Extrapyramidal Disorder |
4.7% |
| Post-traumatic Stress Disorder |
4.7% |
| Psychotic Disorder |
4.7% |
| Bipolar I Disorder |
2.4% |
| Cardiac Disorder |
1.6% |
| Neuralgia |
1.6% |
|
| Visual Impairment |
26.7% |
| Pancytopenia |
20.0% |
| Suicidal Ideation |
20.0% |
| Vomiting |
13.3% |
| Suicide Attempt |
6.7% |
| Urine Analysis Abnormal |
6.7% |
| Yellow Skin |
6.7% |
|
